Skip to content
R&D Changes and Solvent Recycling in Process Development
David CamienerApr 9, 2026 12:33:49 PM5 min read

When Solvent Constraints Slow R&D: Process Development Infrastructure and Section 179 in 2026

Pilot‑scale experimentation can stall due to solvent availability, adversely impacting material flow rather than process development, while driving costs upward unnecessarily. In these environments, solvent recycling can serve to positively impact development infrastructure, supporting pilot runs and process refinement, while reducing reliance on costly purchases and destructive disposal of your used solvents. Recent 2026 tax changes, including restored Domestic Research and Development (R&D) expensing and expanded Section 179 limits, have influenced how these investments are and can be evaluated.

Solvent Constraints in Pilot‑Scale R&D

Solvent handling and availability frequently can become structural bottlenecks in many pilot‑scale environments. Operating volumes are often large enough to strain procurement, storage and disposal systems, yet lack the infrastructure of full-scale production facilities. The result is slower iteration and fewer opportunities to validate process changes, thereby delaying product launches before scale‑up.

In this context, solvent recycling can function as process development infrastructure. By reclaiming solvent for reuse during pilot runs and process refinement, teams reduce dependence on continuous purchasing and disposal, helping maintain development momentum through extended testing and development cycles.

What Changed for R&D Investment in 2026

Recent tax law changes under the One Big Beautiful Bill Act (OBBBA) have shifted how process development investments are evaluated, particularly where R&D activity and capital equipment overlap.

Domestic R&D costs can again be expensed immediately for tax years beginning after December 31, 2024, removing the five‑year amortization requirement that applied from 2022–2024. At the same time, expanded Section 179 limits allow qualifying equipment placed into service to be expensed in the year of purchase, subject to 2026 thresholds.

Together, these changes reduce the financial friction of installing infrastructure that supports active process development—especially in pilot environments bridging R&D and manufacturing.

For a more detailed discussion of Section 179 equipment expensing, including thresholds and “placed‑in‑service” considerations, see our earlier overview on https://www.cbgbiotech.com/blog/section-179-in-2025-cut-taxes-avoid-tariffs-and-invest-in-smarter.

What This Means for Process R&D Teams

For teams responsible for pilot operations and scale‑up readiness, the implications are practical:

  • Solvent‑driven constraints are easier to address through infrastructure planning
  • Development‑support investments are more defensible in budget discussions due to acceleration of deductibility
  • Timing and “placed‑in‑service” decisions carry more weight than in prior years
  • Solvent‑related bottlenecks are now easier to address with reduced cost profiles and liberated resources
  • Equipment that supports iterative process development can be additive to R&D credit calculations
  • Timing with consideration for when systems are placed into service, has become more impactful financially

Eligibility depends on specific facts and should be reviewed with qualified tax advisors. From a process‑development perspective, however, restored R&D expensing and/or expanded Section 179 for accelerated deductibility have shifted how solvent recycling systems are evaluated within R&D planning.

Process R&D By The Numbers

For teams assessing pilot operations and associated financial justification of pilot capacity and capabilities:

Eligibility depends on specific activities and equipment use and should be reviewed with qualified tax professionals. From a process‑development standpoint, however, restored R&D expensing and expanded Section 179 limits have changed how solvent recycling systems are evaluated within R&D planning.

For process R&D teams assessing solvent recycling as a development tool, SolvTrue™ solvent recycling systems are designed to support pilot and process‑development environments.

A Practical Takeaway

Process development aids to reduce uncertainty before scale‑up. When solvent handling and disposal become limiting factors, development timelines can be burdened and slow, even when the process itself is ready. In 2026, restored domestic R&D expensing and expanded Section 179 limits have changed how development‑support infrastructure is evaluated financially, particularly in higher use or valuable solvent pilot environments. For process R&D teams, this is less about tax strategy and more about resource utilization planning flexibility, iteration speed, and risk mitigation before committing to full‑scale production.

If solvent logistics are affecting pilot‑scale work, it may be worth reviewing how those constraints fit into current process‑development planning.

*Consult a qualified tax professional to determine eligibility.

Q&A

Does this change what qualifies as R&D?
No. The One Big Beautiful Bill Act (OBBBA) changes how domestic R&D costs are treated for tax purposes—not what qualifies as R&D. Pilot testing, process refinement, and validation are still evaluated under existing definitions (see Thomson Reuters and RSM).

How does Section 179 apply to process development equipment?
Section 179 allows qualifying equipment placed into service to be expensed immediately, subject to current thresholds. Where equipment supports process development, this can affect planning and timing.

Is solvent recycling an operational or R&D investment?
It depends on use. In pilot‑scale settings, solvent recycling may function as process development infrastructure, supporting experimentation and refinement rather than steady‑state production.

Does eligibility depend on company size or industry?
Yes. Treatment depends on specific activities and equipment use. Applicability should be reviewed with qualified tax professionals.

Sources and Further Reading

Process‑development and pilot‑scale practices referenced in this article draw on guidance and technical resources from organizations including Adesis (process R&D and scale‑up), Sulzer Chemtech (pilot‑scale process testing and separation) and industry tax analysis from firms such as Thomson Reuters, RSM and Grant Thornton regarding 2025–2026 R&D expensing and Section 179 updates.

Check out these other helpful resources:

COMMENTS

RELATED ARTICLES